SOL SPA (QOL) Stock Price & Analysis
QOL Stock Chart & Stats
- Day’s Range
- EUR 59.30 - EUR 60.60
- 52-Week Range
- EUR 44.60 - EUR 63.50
- Previous Close
- EUR 60.10
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 5.42B
- Enterprise Value
- EUR 5.88B
- Total Cash (Recent Filing)
- EUR 312.81M
- Total Debt (Recent Filing)
- EUR 878.27M
- Price to Earnings (P/E)
- 31.3
- Beta
- 0.21
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 0.76%
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth
A multi-year record of positive revenue growth indicates sustained demand and business expansion rather than reliance on a single reporting period. The 2025 re-acceleration provides additional support that the company can continue building its revenue base over the next several quarters.
Stable Operating Profitability
Stable mid-teens EBIT margins and consistently strong EBITDA margins show that the company has maintained meaningful operating profitability as revenue expanded. This provides an earnings foundation for continued investment and helps absorb moderate changes in demand or operating conditions.
Healthy Returns And Reasonable Leverage
A generally reasonable leverage profile combined with sustained mid-teens returns on equity indicates that the company has been using its capital productively. This supports financial resilience and suggests that the existing business can generate attractive returns without depending on excessive balance-sheet leverage.
Bears Say
Declining Free Cash Flow
Declining free cash flow reduces the amount of internally generated funding available for investment, debt reduction, and shareholder returns. Although the company remains profitable, weaker cash generation relative to earnings could constrain financial flexibility if the pressure persists over coming quarters.
Rising Leverage
The 2025 increase in debt and debt-to-equity represents a deterioration in balance-sheet direction even though leverage remains broadly reasonable. Higher leverage can reduce flexibility, increase exposure to financing costs, and leave fewer resources available if earnings soften or investment needs rise.
Gross Margin Volatility
Significant gross-margin volatility introduces uncertainty into earnings quality because it may reflect changing input costs, pricing, or product mix. If this variability continues, it could make profitability less predictable and place greater pressure on the company to preserve stable EBIT margins.
SOL SPA News
QOL FAQ
What was SOL SPA’s price range in the past 12 months?
What is SOL SPA’s market cap?
When is SOL SPA’s upcoming earnings report date?
How were SOL SPA’s earnings last quarter?
Is SOL SPA overvalued?
Does SOL SPA pay dividends?
What is SOL SPA’s EPS estimate?
How many shares outstanding does SOL SPA have?
What happened to SOL SPA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of SOL SPA?
What is the TipRanks Smart Score and how is it calculated?
Company Description
SOL SPA
SOL S.p.A., a global enterprise established in Monza, Italy, in 1927, operates as a subsidiary of Gas and Technologies World BV. The company primarily focuses on the research, manufacturing, and distribution of a diverse array of technical and medical gases, while simultaneously delivering comprehensive home healthcare solutions and associated medical equipment. Its extensive gas portfolio includes vital elements such as oxygen, nitrogen, and argon, alongside specialized gas mixtures, high-purity gases for the electronics industry, and food-grade gases. These products are supplied to various sectors including chemical, electronics, steel, metal, and food processing, as well as supporting environmental protection, scientific research, and healthcare. In the realm of home healthcare, SOL provides critical in-home therapies like oxygen, mechanical ventilation, and aerosol treatments. It also specializes in the diagnosis and management of respiratory sleep disorders, offers artificial nutrition programs, insulin pump therapy, immunotherapy, and dedicated support for pain and Parkinson's disease. Further extending its healthcare reach, the company delivers general home health and social care services, augmented by telemedicine platforms, digital health tools, and a range of healthcare aids. Beyond these core gas and home healthcare operations, SOL S.p.A. engages in a variety of complementary ventures. These encompass the design, construction, and management of biobanks; the generation and sale of hydroelectric power; and the provision of pre- and post-natal diagnostic screening. The company also develops and markets diagnostic systems and products for research and clinical applications across hospital, environmental, veterinary, and food sectors, alongside specialized bioshipping services for the secure transfer, storage, and handling of biological samples. Additional services include professional training, electromedical equipment support, hospital hygiene, environmental monitoring, and ambulance management, all facilitated by its proprietary InfoHealth SOLution web platform for operational oversight.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Aldo Fumagalli Romario
- Employees
- 8,000
- Website
- www.solgroup.com
- Address
- Via Borgazzi, 27, Monza, MI, 20900, IT
SOL SPA (QOL) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 3 | 5 |
| Technical Analysis | 2 | 3 | 5 |
| Moving Averages | 12 | 0 | 0 |


